In line with these results, we identified increased soluble GPR56 (sGPR56) in the serum of RA, but not systemic lupus erythematosus, Sjogren’s syndrome, or ankylosing spondylitis patients [131]. Here, ADGRG1 is linked to rheumatoid arthritis.